{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:50:04Z","timestamp":1762876204986,"version":"3.40.4"},"reference-count":18,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Rep Oncol"],"abstract":"<jats:p>Patients with advanced-stage mycosis fungoides (MF) and S\u00e9zary syndrome (SS) have a poor prognosis. Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment option; however, since most patients with MF\/SS are elderly, they often have difficulty in finding HLA-matched donors. In recent years, HCT from HLA-haploidentical donors (haplo-HCT) using posttransplant cyclophosphamide (PTCy) as graft-versus-host disease prophylaxis has been conducted for patients without HLA-matched donors. Infectious complications, particularly cutaneous bacterial infections, are common among patients with MF\/SS. The lower incidence of severe infectious complications after haplo-HCT than after an unrelated cord blood transplantation could lead to lower transplant-related mortality. Here, we report on a patient with SS who was treated successfully with haplo-HCT with PTCy. The patient has remained in complete remission for more than 24 months. <\/jats:p>","DOI":"10.1159\/000509347","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T21:01:01Z","timestamp":1598994061000},"page":"1053-1058","source":"Crossref","is-referenced-by-count":3,"title":["Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for S\u00e9zary Syndrome"],"prefix":"10.1159","volume":"13","author":[{"given":"Madoka","family":"Kanda-Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24876"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.02.027"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.019"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.125"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3241"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8301"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.16"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.161"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv473"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2016.01.007"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.98"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz099"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-344853"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2018.02.016"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1658106"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1886"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-10-1247"}],"container-title":["Case Reports in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/509347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/509347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:46:20Z","timestamp":1745423180000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000509347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,9,22]]}},"URL":"https:\/\/doi.org\/10.1159\/000509347","archive":["Portico"],"relation":{},"ISSN":["1662-6575"],"issn-type":[{"type":"electronic","value":"1662-6575"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}